Mon, Sep 1, 2014, 7:27 PM EDT - U.S. Markets closed for Labor Day


% | $
Quotes you view appear here for quick access.

PolyMedix, Inc. Message Board

bocamp1 167 posts  |  Last Activity: 2 hours 52 minutes ago Member since: Oct 13, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • All relates to CHF. Heres a release from Cyberonics. Note the very slight improvement in in ejection. This is no better than eecp. But, thanks to Ma, we have NO studies

    Cyberonics is the leading proponent of such therapy and the six-month heart failure trial, involving 60 patients, used its system to stimulate both the left and right-sided vagus nerve.
    Patients, on average, showed a 4.5 percent improvement in left ventricular ejection fraction, a key measure of heart function, the study found, and there was no difference in the results between the left and right sides.
    "I think, at six months, that (4.5 percent improvement) is a very impressive achievement," study leader Inder Anand from the University of Minnesota told reporters at the European Society of Cardiology annual meeting

    Boston Scientific studies failed and Novartis's pill is called "ground breaking" for improving death rates form 17% standard care to 13%. And Cyberonics "very impressive.?" Give me a break. The bar is low on all these treatments and yet Ma has given up on EECP; at a time where the market is 'begging" for a cost effective, cost reducing(hospital stays) solution.
    Studies by vaso should have started 3 years ago, when vaso got a lifeline from GE. Instead, our Chinese CEO decided to put all our cards on his "motherland" by buying Chinese company. Ma is a failure and strategy is same. China is a money pit for VASO. Ma should be FIRED. Castle awards Ma a 600,000 dollar a year financial package. And, Castle gets paid right back for his "excellent' work on the compensation committee. Whats wrong with this picture???????????????

  • bocamp1 by bocamp1 Aug 29, 2014 10:24 AM Flag

    The days of this company remaining independent are few.

  • Reply to

    Talking Head/CNBC

    by bocamp1 Aug 28, 2014 2:58 PM
    bocamp1 bocamp1 Aug 28, 2014 4:45 PM Flag

    Buyer of options. Dec 17 calls at 1.2

  • Just recommended this little gem ; says trading at the biggest discount to NAV in the group. Cheap.

    A highlander hit and its off to the races

  • Over the years since the GE agreement, Ma has made forward statements(implied and outright) at many quarterly CCs. Here are just a few;
    -We are working with getting new agreements with OEM's. This relates to having sales force sell other brand name medical devises. New hire from Seimans implied that might be one company. But, NOTHING
    -Getting more devices from GE to sell. But, NOTHING
    - Very excited about prospects in India for EECP. But, NOTHING
    -Great accretive acquisition in China. Stock was almost 2 times higher when done. A Bold face Lie. Worse than NOTHING
    -2 years and 3 million share giveaway to RIOS. We will be getting expanded insurance coverage. But, NOTHING
    -Company sponsored stroke trial to start. But, NOTHING
    -We will be profitable 2 Q's ago. But, NOTHING
    -We are working with CMS on the CED program for EECP. But, NOTHING
    -Ma says company undervalued and he will buy some in personal account. Then, reconsiders....So, NOTHING
    -Ma says we haven't given up on EECP.....
    -Ma says we are a growth company.....
    Ma says buyback wasn't to accommodate Dempsey shares.......
    Wow, this guy really earns his 600,000 dollar pay package.

  • Reply to

    Great company, Great innovation, Yet Overvalued

    by enrjrr Aug 15, 2014 8:36 AM
    bocamp1 bocamp1 Aug 27, 2014 10:26 AM Flag

    Good luck there Ms Yellen. Celgene to buy very soon, so you might be waiting some time on those lower prices.

  • Reply to

    RGDO- Don Esley

    by drpiano5 Aug 26, 2014 10:26 AM
    bocamp1 bocamp1 Aug 26, 2014 5:23 PM Flag

    If I remember correctly, he invested 5000 in one of the note deals. RGDO has a mission statement in the cardio area. And TB4 has that potential in the same area. At least we could sell them that indication for a couple mil.

  • Below comment from blog. Vaso demonstrated Mobi in live setting.

    We appreciate the opportunity to work with the Bangpakok Hospital Group to explore various applications of our products. In addition to providing remote viewing capabilities of monitoring a patient’s vital signs, thereby enabling consultation from a distant location, the MobiCare system also presents as a great ally in the battle against highly contagious diseases, such as Ebola, by minimizing exposure to only necessary physical contact between the patient and care staff.

  • Reply to

    RGDO- Don Esley

    by drpiano5 Aug 26, 2014 10:26 AM
    bocamp1 bocamp1 Aug 26, 2014 4:32 PM Flag

    That company has no pipeline and a 40 mil market cap and 70 mil in cash. They should buy rgrx.

  • bocamp1 by bocamp1 Aug 26, 2014 10:13 AM Flag

    Tonight, No.1 inversion play: ALKS

  • Reply to

    Nice Tick

    by bocamp1 Aug 13, 2014 10:06 AM
    bocamp1 bocamp1 Aug 25, 2014 9:55 AM Flag

    Once again, right on the offer; 67.700 shares at .14. Big blocks now are all quietly buyers.
    Accumulation continues

  • Big call volume

  • In the next few weeks vaso travels to Spain and then Singapore to showcase products. Ma has been spending money showcasing around the world for years. What is the return? When will we get a cost/benefit of these paid "vacations." For years now, shareholders have seen nothing get to the bottom line.
    Company should take a break from these super expensive trips for a while and cut those expenses for a Q or 2 so we really get to profitability. Wake up Ma. Shareholders are sick of your incompetence Stop wasting OUR money

    September 9 -11, 2014 in Suntec, Singapore.

  • Reply to

    Call Volume

    by bocamp1 Aug 20, 2014 10:27 AM
    bocamp1 bocamp1 Aug 20, 2014 7:58 PM Flag

    Your a real pro. Who's touting anything here. What rumor? Was it even mentioned on CNBC? no. Maybe, if you knew how to read the real options signals from the noise, you might make a little money following option activity.

  • Reply to

    Looking for breakout

    by aenzrpaide Aug 19, 2014 11:26 AM
    bocamp1 bocamp1 Aug 20, 2014 1:41 PM Flag

    Calls say yes also. Over 12,000 aug 29th 31 calls done today; bullish earnings play. No puts done against them and OI nothing. One tick of 8000 at the offer of 1.45. Get long

  • Reply to

    Call Volume

    by bocamp1 Aug 20, 2014 10:27 AM
    bocamp1 bocamp1 Aug 20, 2014 1:17 PM Flag

    Really? Maybe you could explain that statement. Or not, since it is based on nothing.

  • bocamp1 by bocamp1 Aug 20, 2014 10:27 AM Flag

    Very unusual for this stock. Check out oct calls. Consolidation?????????

  • Reply to

    Trial Delay

    by sdhoolteach2000 Aug 18, 2014 10:51 AM
    bocamp1 bocamp1 Aug 18, 2014 12:54 PM Flag

    maybe we would not have been around 11 cents recently

    Exactly. Stop whining a buy on these dips. No one knows more about company than the few here. And yet, all you do sno is point to the inefficiencies of management instead of taking advantage of same. Why bother posting and following??????????????????????

  • Reply to


    by bocamp1 Jul 29, 2014 2:09 PM
    bocamp1 bocamp1 Aug 16, 2014 6:29 PM Flag

    That one has been a disappointment. Cooperman hasn't sold but its a relatively small investment for him. 2 of the deepwater wells that gultu has a small interest in just came in dry; thus the recent fall. But, very close to proving a well in Highlander. That is a must hit or further down it goes. This well looks good from prelims but must prove.
    Still really like action here. Reminds me of the fight around a buck before it took off.

  • Reply to

    Vaso's Directors and Officers Are a Greedy Disgrace

    by bocamp1 Aug 15, 2014 6:28 PM
    bocamp1 bocamp1 Aug 16, 2014 2:14 PM Flag

    Every Vaso shareholder should take 5 minutes out of their day and write a letter to vaso detailing their anger with Ma's payment package in regard to another missed Quarter and failing equity prices. He is not a top CEO, yet he takes top dollar from shareholders.
    His position is indefensible.
    We demand a pay package that is in line with shareholder returns.

0.020.00(-0.50%)Aug 29 2:03 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Criteo SA
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Yahoo! Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT